Workflow
Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
CRSPCRISPR Therapeutics(CRSP) The Motley Fool·2024-04-05 09:03

These companies are in the early days of their growth stories.If you're looking to add some growth to your portfolio, a great way to do it is by picking up shares of a biotech company with a recently approved product. Such a treatment will represent a brand new revenue driver for the company -- and sometimes, even its first one -- so if the product takes off, the share price may follow. In many cases, this marks the very start of the biotech's growth story, allowing you to get in early and benefit over time ...